Chapter 19: Drugs That Block Nicotinic Cholinergic Transmission

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace, the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we think about the human body, we marvel at how automatic it is.

Like, you touch a hot stove and your hand just jerks back.

Right.

Before you even consciously register the pain.

Exactly.

It's this flawless,

instantaneous electrical system.

It's hardwired for survival, really.

I mean, the neuromuscular reflex, the ability to instantly contract a muscle to escape danger is basically our most fundamental fail safe.

But you know, to perform modern medicine, we sometimes have to completely dismantle that survival system.

We do.

If you're going to perform invasive surgery or insert a breathing tube, you just can't have the body fighting back with those automatic reflexes.

So today we're taking a deep dive into the pharmacology of neuromuscular blocking agents.

We're looking specifically at Chapter 19 of LANDS Pharmacology for Nursing Care.

Yes, drugs that block nicotinic cholinergic transmission.

And if you are listening right now, maybe you're a nursing student, you know, fueled by a dangerous amount of coffee, prepping for a massive pharmacology exam.

Well, you are in the exact right place.

We've got you covered.

Our mission today is to take this really dense chapter, translate it into plain language and go right in the order of the text so you can master these crucial meds.

We're going to decode the mechanisms, the severe clinical risks and the nursing implications that honestly keep patients alive when their fail safes are turned off.

And these medications are profound.

I mean, neuromuscular blocking agents do one highly specific thing.

Which is?

They prevent the neurotransmitter acetylcholine from activating the nicotinic M receptors on skeletal muscle.

And the M stands for muscle, right?

Right.

Nicotinic muscle receptors.

The clinical result of blocking them is flaccid paralysis.

Just complete whole -body muscle relaxation.

But before we can understand how to safely cause that paralysis, we kind of have to look at the baseline physiology of how a nerve signal translates into physical movement in the first place.

Yeah.

The process of excitation -contraction coupling.

Since we're dealing with advanced pharmacology, we don't need to rehash basic biology.

But the specific sequence at the neuromuscular junction is really key here.

Right.

So it starts with the resting membrane of the muscle cell, which is polarized.

Meaning positive on the outside, negative on the inside.

Exactly.

And then an action potential travels down the motor neuron, hits the terminal, and triggers the release of acetylcholine into that tiny gap, the sub -neural space.

So the acetylcholine crosses the gap, binds to those nicotinic M receptors on the motor end plate,

and that opens the channels.

Which causes this massive rush of positive ions to flood into the cell.

And that, right there, causes the end plate to depolarize.

Like a wave, right?

That wave of depolarization sweeps across the muscle membrane and triggers the sarcoplasmic reticulum.

The muscle's internal calcium vault, basically.

Yeah, the vault.

It releases a massive flood of calcium.

The calcium binds to troponin, exposing the binding sites on actin, which lets the myosin heads grab hold and slide.

And boom, the muscle contracts.

Okay, it's kind of like a relay race baton pass.

The nerve passes the signal to the end plate, which passes it to the vault, which releases the calcium.

That's a great way to picture it.

But to maintain that contraction, say you're holding a heavy box,

the body has to perform a continuous rapid -fire sequence of those baton passes.

Right.

Nerve releases acetylcholine, end plate depolarizes, calcium release, muscle contracts.

Over and over.

But here's the critical physiological quirk that happens between every single nerve impulse.

The cell has to repolarize.

It has to reset.

Exactly.

It has to reset the ionic gradient.

Okay, let's unpack this.

Because the text says, if the motor end plate remains in a depolarized state, contraction actually stops.

Yeah.

And I had to read that twice.

Yeah.

It's counterintuitive.

Right.

Why wouldn't a constant state of depolarization just cause a permanent locked -up muscle cramp?

It comes down to the behavior of the sarcoplasmic reticulum.

That calcium vault requires the alternating cycle of depolarization and repolarization to keep releasing calcium.

Oh, so if the end plate stays depolarized, it's like the signal just gets stuck.

Exactly.

The signal for calcium release just shuts off.

And the sarcoplasmic reticulum acts like an aggressive vacuum.

It actively pumps all the free calcium back inside itself.

And without the calcium in the muscle fiber, the actin and myosin physically can't interact anymore.

Right.

So the muscle goes totally limp,

and this specific requirement for repolarization is exactly how one of our drug classes will induce paralysis later on.

It's a biological loophole.

A very useful one.

Okay, so now that we know how muscles work and how they fail,

why would a nurse or doctor want to artificially paralyze them?

Well, surgery is the obvious one.

If a surgeon is operating on the abdomen, they need the abdominal wall muscles completely flaccid.

Otherwise, they're fighting tense, rigid tissue.

That makes sense.

But beyond making the tissue pliable, the text mentions an anesthesia sparing effect.

What is that?

So general anesthesia is actually incredibly dangerous at high doses.

It depresses the cardiovascular and respiratory systems.

Right.

You don't want to give more than you have to.

Exactly.

So if a surgical team pairs a much lighter, safer dose of general anesthetic with a neuromuscular blocker, they get the perfect surgical environment without pushing the patient to the brink of cardiovascular collapse.

Got it.

And they're using the ICU, too, for mechanical ventilation.

Very commonly.

A critically ill patient might have spontaneous, erratic breathing patterns that fight the rhythm of the life support ventilator.

Which can cause dangerous pressure spikes in their lungs, right?

Yes.

So paralyzing the skeletal muscles allows the machine to completely control oxygenation.

Providers also use them for endotracheal intubation to suppress the gag reflex.

And as an adjunct to electroconvulsive therapy, or ECT, right?

To prevent patients from suffering violent bone fractures or muscle tears during the therapeutically induced seizures.

Okay, so these uses sound highly beneficial.

But this brings us to a massive safety alert.

The Institute for Safe Medication Practices, the ISMP, classifies neuromuscular blockers as high alert medications.

They absolutely do.

And the reason is rooted in their chemical structure.

These drugs do not cross the blood -brain barrier.

Meaning they have zero effect on the central nervous system.

None.

They do not alter consciousness, they do not sedate, and they do not dull pain.

They simply disconnect the physical body from the brain.

That is horrifying.

The text cites a statistic that is basically the ultimate medical nightmare.

Somewhere between 0 .1 % and 0 .2 % of surgeries involve a patient who is completely paralyzed by these drugs, but fully awake.

Yes, awake and able to feel everything due to inadequate general anesthesia.

It sounds like being trapped in a locked box.

I mean, you feel the incision, you hear the staff, but you can't move a vocal cord to speak, you can't open an eyelid, you can't even breathe faster to show you're in pain.

The psychological trauma of that is unimaginable.

So what does this all mean for the nurse at the bedside treating a ventilated patient in the ICU?

It translates to a direct non -negotiable nursing implication.

Because the patient cannot give you any behavioral cues, no grimacing, no pulling at tubes, you have to assume they're fully awake.

Always assume they're awake.

Yes.

You must administer prescribed sedatives and analgesics around the clock to prevent suffering.

Right, because the paralytic is not treating their pain or anxiety.

Not at all.

You also have to ensure their physical comfort.

You're doing passive range of motion, lubricating their eyes because they can't blink, and you have to carefully guard what is spoken in the room.

Hearing a grim prognosis while locked inside a paralyzed body, I mean, the nurse is the primary barrier preventing that trauma.

Absolutely.

Okay, with the stakes clearly set, let's dive into the first of the two major classes of these drugs, the competitive or non -depolarizing neuromuscular blockers.

And we should acknowledge their historical origin here.

Tubocuririn, derived from curare.

The poison used on blow darts by South American indigenous hunters, right, to paralyze their prey.

That's the one.

Modern chemistry refined that molecule into the drugs we use today.

And if we look at the chemistry of the competitive blockers in figure 19 .3, they all share a defining characteristic.

Which is?

Every drug in this class contains at least one quaternary nitrogen atom.

A quaternary nitrogen atom.

Okay, so this means they carry a positive charge.

And in pharmacology, a highly charged polar molecule is hydrophilic and lipophobic.

Right, meaning it cannot dissolve into or easily cross the lipid bilayer of cellular membranes.

So that dictates three massive clinical facts.

First, they can't be absorbed from the GI tract, so no oral administration.

Four only.

Exactly.

Second, as we just covered, they cannot cross the lipid -rich blood -brain barrier.

No CNS effects.

And third, they don't readily cross the placenta.

So they can be used in pregnant patients without paralyzing the fetus.

Which is a huge clinical advantage.

Let's talk about the mechanism of action, shown in figure 19 .4.

It's competitive antagonism.

They compete with natural acetylcholine for the nicotinic M receptors.

Right, they bind to the receptor, but they do not activate it.

I picture it like someone jamming a fake key into a lock.

The key fits, but it doesn't turn the lock.

So the door doesn't open, there's no depolarization.

But because the fake key snaps off inside, the real key, the acetylcholine, can't get in either.

That's a perfect visual.

The muscle is essentially starved of the signal.

But here's where it gets really interesting.

If it's competitive, does that mean if we just flood the area with enough natural acetylcholine, we can wash the drug out and restore muscle function?

That is exactly right.

And that beautifully sets up the antidote for this class of drugs.

The cholinesterase inhibitors.

Right.

Drugs like neostigmine.

See, acetylcholinesterase is the enzyme in the gap that constantly breaks down acetylcholine.

It clears the space.

So if we give an inhibitor, we stop that cleanup process.

Yes.

Acetylcholine builds up rapidly, floods the junction, outnumbers the blocker molecules, and physically displaces them.

Muscle function returns.

So once that fake key is in the lock, what actually happens to the patient's body over the next hour?

What's the progression of the paralysis?

It happens in a very specific order.

It doesn't just hit the whole body at once.

The smallest, most rapidly firing muscles are paralyzed first.

So eyelids and jaw.

Exactly.

Eyelids and muscles of mastication first.

Then the paralysis descends to the limbs, the abdomen, and the glottis.

And the respiratory muscles are last.

Right.

The intracostals and the diaphragm are the heavy lifters, so they succumb last.

And when the drug wears off, it happens in the exact reverse order.

The diaphragm wakes up first.

Exactly.

Okay, what about adverse effects?

The text mentions hypotension can occur.

Yeah, that's a big one.

It's due to histamine release from mast cells, which causes vasodilation, or it can be from partial blockade at the autonomic ganglia.

And there are specific precautions, right?

Like myasthenia gravis or MG.

Oh, this is a huge clinical point.

Patients with MG have an autoimmune condition that destroys their nicotinic M receptors.

They have very few of them to begin with.

So going back to the lock and key, they start with way fewer locks.

Exactly.

Meaning they are incredibly sensitive to these drugs.

What would be a normal dose for you or me could cause complete prolonged paralysis in an MG patient.

Wow.

And electrolyte disturbances matter, too.

Low potassium, hypokalemia actually enhances the paralysis.

It does.

And we have to watch out for drug interactions.

General anesthetics enhance the blockade, and so do certain antibiotics like aminoglycosides and tetracyclines.

Okay, wait.

If my patient is on an aminoglycoside antibiotic, like Jim Tamsen, and we give a competitive blocker, it sounds like 1 plus 1 equals 3.

It really does.

Aminoglycosides can depress neuromuscular transmission on their own.

How does the nurse monitor for toxicity there?

Toxicity looks like prolonged apnea.

The patient just won't start breathing on their own when they're supposed to.

So the nursing implication is immediate respiratory support, staying on the vent, and administering that colon esterase inhibitor we talked about.

Right, to force the reversal.

And giving antihistamines if hypotension from histamine release occurs.

Alright, so we understand the class.

But chapter 19 has this big clinical decision tool, table 19 .1.

How does a provider actually choose a specific drug from the cart?

It all comes down to how the patient's body eliminates the drug.

Table 19 .1 is basically a matchmaking game between the drug's pharmacokinetic profile and the patient's organ function.

Okay, let's break it down.

Pancoronium is the prototype.

Yes, and it's excreted primarily by the kidneys with some liver metabolism.

It's also unique because it has vagalytic properties, meaning it blocks the vagus nerve, which can cause tachycardia.

So if I have a patient with end -stage renal disease, I'm mentally crossing pancoronium off the list, right?

Absolutely.

Their kidneys can't clear it, so it would dangerously accumulate.

For renal or hepatic failure patients, you're looking at atrichurium or sysatrichurium.

Because they don't rely on the kidneys or the liver.

Right, it's a brilliant workaround.

Atrichurium is eliminated by plasma cholinesterase, an enzyme freely circulating in the blood.

Though the text does say atrichurium causes a lot of histamine release.

It does, but sysatrichurium is like the upgraded version.

It undergoes Hoffman elimination.

Meaning it degrades completely spontaneously.

Yes, just based on physiological pH and temperature in the blood, no organs needed, and it causes minimal histamine release.

That is incredible.

Okay, what if you need a really short duration?

Mevecurium is your go -to.

It's rapidly hydrolyzed.

And what if I need the fastest possible onset among the competitive agents?

That would be rocoronium.

It works in about one to three minutes.

And vecuronium?

Vecuronium is excreted primarily in the bile, so you have to avoid it in patients with severe liver dysfunction.

Okay, so the nursing assessment of liver and kidney function directly impacts medication safety here.

It's not just following orders, it's verifying the match.

Exactly, it's critical thinking at the bedside.

But what if rocoronium's one to three minutes isn't fast enough?

Like you have an emergency airway situation, you need paralysis right this second, but only for a very short time.

That brings us to our second class of drugs.

And there is only one drug in this class currently in clinical use.

Cetalcholine.

Cetalcholine.

It is a depolarizing neuromuscular blocker.

So the mechanism is totally different from the competitive blockers.

Completely different.

It binds to the nicotinicam receptors, but instead of just blocking them, it actually activates them.

It causes depolarization.

Which means the muscles contract at first?

When you push the drug 5e, the patient actually twitches.

We call these brief transient muscle contractions fasciculations.

But then it doesn't let go.

Exactly.

It acts like natural acetylcholine for one millisecond, but then it stubbornly stays attached to the receptor.

It keeps the motor end plate in a state of constant depolarization.

And going back to the physiological loophole from the beginning of the deep dive, because the muscle can't repolarize, the calcium gets sucked back up and the muscle goes totally flaccid.

You've got it.

It causes flaccid paralysis by locking the system in the on position.

And the pharmacokinetics are wild.

It's ultra short acting.

Peaks in one minute, fades in 4 to 10 minutes.

Which makes it absolutely perfect for endotracheal intubation and ECT.

The rapid fade happens because succinylcholine is degraded by an enzyme in the blood called

pseudocolinesterase.

Wait.

Pseudocolinesterase.

Okay.

With the competitive blockers, we used a cholinesterase inhibitor to reverse the paralysis.

Since succinylcholine is degraded by a type of cholinesterase, does that mean cholinesterase inhibitors reverse this one too?

No.

And I am so glad you paused on this because this is a massive, highly testable safety alert.

It is the exact opposite.

Oh, wow.

So what happens if you give an inhibitor?

If you give a cholinesterase inhibitor to a patient on succinylcholine, you decrease the enzyme that breaks the drug down.

You're stopping the cleanup.

So you would actually intensify and prolong the paralysis.

Yes.

There is no specific antidote for succinylcholine.

Management of an overdose or prolonged effect is purely supportive.

Wow.

That is a trap you do not want to fall into.

It really is.

And because succinylcholine forces the muscle to depolarize first, it triggers a completely unique set of adverse effects, right?

Things we don't see with the competitive blockers.

Yes.

And every nurse must memorize these.

First is prolonged apnea in patients with a genetic defect.

Right.

Some people have low pseudocholinesterase activity genetically.

Yeah.

So a standard dose could paralyze them for hours instead of minutes.

If their genetic history is unknown, providers will sometimes give a tiny test dose first to see if the response is exaggerated.

That makes a lot of sense.

But the scariest one has to be malignant hyperthermia.

It is terrifying.

It's a rare, potentially fatal genetic reaction.

The succinylcholine triggers a massive uncontrolled release of calcium from the sarcoplasmic reticulum.

So the muscles just lock up into severe rigidity.

Yes.

And it causes this hypermetabolic state.

The patient's body temperature can rapidly spike to 43 degrees Celsius.

Which is over 109 degrees Fahrenheit.

That is lethal.

What's the treatment?

Stop the drug instantly.

Cool them with ice packs and cold IV saline.

But the real lifesaver is administering 5E dantrolene.

Dantrolene.

Right.

It works directly inside the muscle cell to block that calcium release and halt the heat generation.

OK.

Noted.

Dantrolene for malignant hyperthermia.

Another adverse effect is postoperative muscle pain just from those initial fasciculations.

Yes.

The muscles get a violent workout before they paralyze.

But there's one more major risk that requires serious nursing advocacy.

Hyperkalemia.

Succinylcholine promotes potassium release.

Right.

When it depolarizes the cell, some potassium leaks out into the blood.

In a healthy person, it's no big deal.

But the tech says it's strictly contraindicated in patients with major burns,

multiple trauma, and denervation of skeletal muscle.

Because in those patients, the damaged muscle cells have upregulated.

They've sprouted millions of extra nicotinic M receptors all over the cell membrane.

So if I see a trauma patient rolling into the ER with severe burns, and the doctor calls for rapid sequence intubation with succinylcholine, I need to speak up immediately, right?

You absolutely do.

If you give succinylcholine to a burn patient, it hits all those millions of extra receptors at once.

It floods the blood with potassium.

And sudden, severe hyperkalemia leads to cardiac arrest.

Exactly.

The drug meant to secure their airway will stop their heart.

This is where the nurses' role as the final safety checkpoint literally saves lives.

You have to advocate for a competitive blocker instead.

That is heavy.

But it's exactly why we need to understand the pharmacology.

Right.

Let's recap this journey.

We traced the normal physiology of muscle contraction, how the action potential relies on ascetalcholine and calcium.

We learned how competitive blockers like pancoronium wedge themselves into the receptor to block the signal without activating it.

And we saw how the depolarizing blocker succinylcholine holds the receptor hostage in a depolarized state.

We covered the crucial nursing implications, too.

Always, always provide sedation and analgesia because they are awake.

Monitor potassium levels, check liver and kidney function, and watch out for malignant hypothermia.

It's a lot to manage, but it's vital.

It is.

You have a final thought to leave the listener with as they head back to study?

I do.

Given how incredibly dangerous succinylcholine side effects can be, you know, from malignant hypothermia to fatal hyperkalemia, how much longer will it remain our go -to for rapid intubation?

That's a great question.

What might the future of pharmacology look like as we try to engineer an ultra -short acting drug that completely bypasses these genetic roulette risks?

Something with the speed of succinylcholine, but the safety of a competitive blocker.

That is something to mull over.

Well, the nursing student listening right now, you've got this.

You understand the why behind the what, and that is how you become a great nurse.

Thanks for studying with us, and a warm thank you from the Last Minute Lecture team.